JENNIFER WHEELER: Open Payments
NPI 1669618427 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 37 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $329 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $216 |
| Neurocrine BioSciences, Inc. | 5 | $160 |
| Alkermes, Inc. | 5 | $149 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ABBVIE INC. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: CAPLYTA, INGREZZA, ARISTADA, COBENFY, Auvelity, FANAPT, VRAYLAR, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
